LRRC15-antiTGFβR2

N/A

Report date: 2025/02/18 16:45:48

Base Information

Drug NameLRRC15-antiTGFβR2
Drug Alias NameLRRC15-dependent anti-TGFβR2
ClassificationBiologics > Protein drugs
Mechanisms of ActionTransforming growth factor beta receptor 2 inhibitors
TargetsTransforming growth factor beta receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBonum Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBonum Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A